Removal of endogenous leptin from the circulation by the kidney

International Journal of Obesity

Volumn 21, Issue 6, 1997, Pages 495-504

  Cumin, F ^a   Baum, H P ^a   De Gasparo, M ^a   Levens, N ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Kidney; Leptin; Nephrectomy; Obesity; Ureteral ligation; Zucker (fa fa) rats

Indexed keywords

LEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL BLOOD; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; KIDNEY CIRCULATION; KIDNEY PLASMA FLOW; KIDNEY TUBULE; MALE; METABOLISM; NEPHRECTOMY; NONHUMAN; OBESITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; URETER LIGATION; URINARY EXCRETION; URINE LEVEL;

EID: 0030927377     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800428     Document Type: Article

References (28)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
2. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540.
3. Rentsch J, Levens N, Chiesi M. Recombinant ob-gene product reduces food intake in fasted mice. Biochem Biophys Res Comm 1995; 214: 131.
4. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543.
5. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546.
6. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature 1996; 380: 677.
7. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RJ. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263.
8. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (OB-Rb) in mouse hypothalamus and adjacent brain regions by in-situ hybridization. Febs Letters 1996; 387: 113-116.
9. Cioffi JA, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D, Snodgrass HR. Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction. Nature Medicine 1996; 2: 585.
10. Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D. Renal filtration, transport, and metabolism of low-molecular-weight protein: A Review. Kidney Int 1979; 16: 251.
11. Gibbons JA, Luo Z-P, Hannon ER, Braeckman RA, Young JD. Quantitation of the renal clearance of interleukin-2 using nephrectomized and ureter-ligated rats. J Pharm Exp Ther 1995; 272: 119.
12. Cumin F, Baum H-P, Levens N. Leptin is cleared from the circulation primarily by the kidney. Int J Obes 1996; 20: 1120.
13. 2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system. Eur J Pharmacol 1994; 259: 27.
14. Gibaldi M, Perrier D. Pharmacokinetics, 2nd edn. Marcel Dekker: New York, 1982.
15. Kim DC, Reitz B, Carmichael DF, Bloedow DC. Kidney as a major clearance organ for recombinant human interleukin-1 receptor antagonist. J Pharm Sci 1996; 84: 575.
16. Mitch WE, Collier VU, Walser M. Creatinine metabolism in chronic renal failure. Clin Sci 1980; 58: 327.
17. Bauer JH, Brooks CS, Burch RN. Clinical appraisal of creatinine clearance as a measure of glomerular filtration rate. Am J Kidney Dis 1982; 1: 337.
18. Lau D, Mallard S, Wariner G, Watson A, Cheung E, Young J. Pharmacokinetics of recombinant human leptin in mice. Obes Res 1996; 4: 38S (Abstract).
19. West DB, Prinz WA, Francendese AA, Greenwood MR. Adipocyte blood flow is decreased in obese Zucker rats. Am J Physiol 1987; 253: R228.
20. Kurtz TW, Morris RC, Pershadsingh HA. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 1989; 13: 896.
21. Cray GS, Swan SK, O'Donnell MP, Kasiske BL, Katz SA, Keane WF. The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats. J Am Soc Nephrol 1995; 6: 1295.
22. Schmitz PG, O'Donnell MP, Kasiske BL, Katz SA, Kesane WF. Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. Am J Physiol 1992; 263: F496.
23. Harker CT, O'Donnell MP, Kasiske BL, Keane WF, Katz-SA. The renin-angiotensin system in the type II diabetic obese Zucker rat. J Am Soc Nephrol 1993; 4: 1354.
24. Skorecki KL, Nadler SP, Badr KF, Brenner BM. Renal and systemic manifestations of glomerular disease. In: Brenner BM, Rector FC (eds). The Kidney. W.B. Saunders Co: Philadelphia, 1986, pp 891.
25. Alavi FK, Zawada ET, Simmon JL. Renal hemodynamics and histological consequences of diets high in unsaturated fat, protein or sucrose in obese Zucker rats. Clin Nephrol 1995; 43: 112.
26. Dal Canton A, Stanziale R, Corradi A, Andreucci VE, Migone I. Effects of acute ureteral obstruction on glomerular hemodynamics in rat kidney. Kidney Int 1977; 12: 403.
27. Harris RH, Gill JM. Changes in glomerular filtration rate during complete ureteral obstruction in rats. Kidney Int 1981; 19: 603.
28. Klahr S, Buerkert J, Morrison A. Urinary Tract Obstruction. In: Brenner BM, Rector FC (eds). The Kidney. W.B. Saunders Co: Philadelphia, 1986, pp 1443.